12th Annual FDA/Alzheimer’s Disease Allies Meeting

Diversifying the Therapeutic Pipeline for Alzheimer's Disease: From Targets to Trials

The Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD) Coalition’s 12th Annual FDA/Alzheimer’s Disease Allies Meeting, Diversifying the Therapeutic Pipeline for Alzheimer’s Disease: From Targets to Trials, will take place Wednesday, November 13, 2019 at The Bethesdan Hotel.

For more information, visit https://act-ad.org/event/12th-annual-fda-alzheimers-disease-allies-meeting/.